QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

Name: QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy
Published: 2025
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

cervicalcancer immunotherapy pd

cervical cancer, cervical cancer metastatic, cervical cancer recurrent, cervical adenocarcinoma, cervical cancer squamous cell, immunotherapy, pd-1/ctla-4 bispecific antibody, ql1706, pd-1 resistant, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

Related documents